CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: Weight-based Dosing in Hemophilia A [Phase 2]
Summary
Phase 2 trial investigating weight-based dosing in Hemophilia A has terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Craig Seaman | Conditions: Hemophilia | Phase 2 | Status: TERMINATED | Results posted: 2020-09-25